[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Drugs for Osteoarthritis Pain Sales Market Report 2017

January 2017 | 125 pages | ID: G3487F940E7EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:


Sales, means the sales volume of Drugs for Osteoarthritis Pain

Revenue, means the sales value of Drugs for Osteoarthritis Pain

This report studies sales (consumption) of Drugs for Osteoarthritis Pain in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Abbott Laboratories
  • Johnson & Johnson
  • Novartis International
  • Pfizer
  • AbbVie
  • Abiogen Pharma
  • Afferent Pharmaceuticals
  • Astellas Pharma
  • BioDelivery Sciences International
  • CrystalGenomics
  • Cytori Therapeutics
  • Daiichi Sankyo
  • Eli Lilly
  • Endo Pharmaceuticals Holdings
  • Horizon Pharma
  • ICeutica
  • Iroko Pharmaceuticals
  • Merck
  • Nuvo Research
  • Regeneron Pharmaceuticals
  • Sanofi
  • SantoSolve
  • Techfields Pharma
  • Winston Pharmaceuticals
  • Yooyoung Pharmaceutical
  • Zynerba Pharmaceuticals
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Drugs for Osteoarthritis Pain in these regions, from 2011 to 2021 (forecast), like
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • OTC
  • Prescription
Split by applications, this report focuses on sales, market share and growth rate of Drugs for Osteoarthritis Pain in each application, can be divided into
  • Hospital
  • Clinics
  • Household
Global Drugs for Osteoarthritis Pain Sales Market Report 2017

1 DRUGS FOR OSTEOARTHRITIS PAIN OVERVIEW

1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Classification of Drugs for Osteoarthritis Pain
  1.2.1 OTC
  1.2.2 Prescription
1.3 Application of Drugs for Osteoarthritis Pain
  1.3.1 Hospital
  1.3.2 Clinics
  1.3.3 Household
1.4 Drugs for Osteoarthritis Pain Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Drugs for Osteoarthritis Pain (2011-2021)
  1.5.1 Global Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2021)
  1.5.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)

2 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Drugs for Osteoarthritis Pain Market Competition by Manufacturers
  2.1.1 Global Drugs for Osteoarthritis Pain Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Drugs for Osteoarthritis Pain Revenue and Share by Manufacturers (2011-2016)
2.2 Global Drugs for Osteoarthritis Pain (Volume and Value) by Type
  2.2.1 Global Drugs for Osteoarthritis Pain Sales and Market Share by Type (2011-2016)
  2.2.2 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016)
2.3 Global Drugs for Osteoarthritis Pain (Volume and Value) by Regions
  2.3.1 Global Drugs for Osteoarthritis Pain Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Regions (2011-2016)
2.4 Global Drugs for Osteoarthritis Pain (Volume) by Application

3 UNITED STATES DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

3.1 United States Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  3.1.1 United States Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  3.1.2 United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  3.1.3 United States Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
3.2 United States Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
3.3 United States Drugs for Osteoarthritis Pain Sales and Market Share by Type
3.4 United States Drugs for Osteoarthritis Pain Sales and Market Share by Application

4 CHINA DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

4.1 China Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  4.1.1 China Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  4.1.2 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  4.1.3 China Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
4.2 China Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
4.3 China Drugs for Osteoarthritis Pain Sales and Market Share by Type
4.4 China Drugs for Osteoarthritis Pain Sales and Market Share by Application

5 EUROPE DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  5.1.1 Europe Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  5.1.2 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
5.2 Europe Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
5.3 Europe Drugs for Osteoarthritis Pain Sales and Market Share by Type
5.4 Europe Drugs for Osteoarthritis Pain Sales and Market Share by Application

6 JAPAN DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  6.1.1 Japan Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  6.1.2 Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
6.2 Japan Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
6.3 Japan Drugs for Osteoarthritis Pain Sales and Market Share by Type
6.4 Japan Drugs for Osteoarthritis Pain Sales and Market Share by Application

7 SOUTHEAST ASIA DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  7.1.1 Southeast Asia Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  7.1.2 Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  7.1.3 Southeast Asia Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
7.2 Southeast Asia Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
7.3 Southeast Asia Drugs for Osteoarthritis Pain Sales and Market Share by Type
7.4 Southeast Asia Drugs for Osteoarthritis Pain Sales and Market Share by Application

8 INDIA DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

8.1 India Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  8.1.1 India Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  8.1.2 India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  8.1.3 India Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
8.2 India Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
8.3 India Drugs for Osteoarthritis Pain Sales and Market Share by Type
8.4 India Drugs for Osteoarthritis Pain Sales and Market Share by Application

9 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN MANUFACTURERS ANALYSIS

9.1 Abbott Laboratories
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    9.1.2.1 OTC
    9.1.2.2 Prescription
  9.1.3 Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Johnson & Johnson
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    9.2.2.1 OTC
    9.2.2.2 Prescription
  9.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 Novartis International
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    9.3.2.1 OTC
    9.3.2.2 Prescription
  9.3.3 Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 Pfizer
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    9.4.2.1 OTC
    9.4.2.2 Prescription
  9.4.3 Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 AbbVie
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    9.5.2.1 OTC
    9.5.2.2 Prescription
  9.5.3 AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 Abiogen Pharma
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    9.6.2.1 OTC
    9.6.2.2 Prescription
  9.6.3 Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Afferent Pharmaceuticals
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    9.7.2.1 OTC
    9.7.2.2 Prescription
  9.7.3 Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 Astellas Pharma
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    9.8.2.1 OTC
    9.8.2.2 Prescription
  9.8.3 Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 BioDelivery Sciences International
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    9.9.2.1 OTC
    9.9.2.2 Prescription
  9.9.3 BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 CrystalGenomics
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    9.10.2.1 OTC
    9.10.2.2 Prescription
  9.10.3 CrystalGenomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 Cytori Therapeutics
9.12 Daiichi Sankyo
9.13 Eli Lilly
9.14 Endo Pharmaceuticals Holdings
9.15 Horizon Pharma
9.16 ICeutica
9.17 Iroko Pharmaceuticals
9.18 Merck
9.19 Nuvo Research
9.20 Regeneron Pharmaceuticals
9.21 Sanofi
9.22 SantoSolve
9.23 Techfields Pharma
9.24 Winston Pharmaceuticals
9.25 Yooyoung Pharmaceutical
9.26 Zynerba Pharmaceuticals

10 DRUGS FOR OSTEOARTHRITIS PAIN MAUFACTURING COST ANALYSIS

10.1 Drugs for Osteoarthritis Pain Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain
10.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Drugs for Osteoarthritis Pain Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN MARKET FORECAST (2016-2021)

14.1 Global Drugs for Osteoarthritis Pain Sales, Revenue and Price Forecast (2016-2021)
  14.1.1 Global Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021)
  14.1.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
  14.1.3 Global Drugs for Osteoarthritis Pain Price and Trend Forecast (2016-2021)
14.2 Global Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast by Regions (2016-2021)
  14.2.1 United States Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.2 China Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.3 Europe Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.4 Japan Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.5 Southeast Asia Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.6 India Drugs for Osteoarthritis Pain Sales, Revenue and Growth Rate Forecast (2016-2021)
14.3 Global Drugs for Osteoarthritis Pain Sales, Revenue and Price Forecast by Type (2016-2021)
14.4 Global Drugs for Osteoarthritis Pain Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Osteoarthritis Pain
Table Classification of Drugs for Osteoarthritis Pain
Figure Global Sales Market Share of Drugs for Osteoarthritis Pain by Type in 2015
Figure OTC Picture
Figure Prescription Picture
Table Applications of Drugs for Osteoarthritis Pain
Figure Global Sales Market Share of Drugs for Osteoarthritis Pain by Application in 2015
Figure Hospital Examples
Figure Clinics Examples
Figure Household Examples
Figure United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure Global Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2021)
Figure Global Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Table Global Drugs for Osteoarthritis Pain Sales of Key Manufacturers (2011-2016)
Table Global Drugs for Osteoarthritis Pain Sales Share by Manufacturers (2011-2016)
Figure 2015 Drugs for Osteoarthritis Pain Sales Share by Manufacturers
Figure 2016 Drugs for Osteoarthritis Pain Sales Share by Manufacturers
Table Global Drugs for Osteoarthritis Pain Revenue by Manufacturers (2011-2016)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Drugs for Osteoarthritis Pain Revenue Share by Manufacturers
Table 2016 Global Drugs for Osteoarthritis Pain Revenue Share by Manufacturers
Table Global Drugs for Osteoarthritis Pain Sales and Market Share by Type (2011-2016)
Table Global Drugs for Osteoarthritis Pain Sales Share by Type (2011-2016)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Type (2011-2016)
Figure Global Drugs for Osteoarthritis Pain Sales Growth Rate by Type (2011-2016)
Table Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Type (2011-2016)
Figure Global Drugs for Osteoarthritis Pain Revenue Growth Rate by Type (2011-2016)
Table Global Drugs for Osteoarthritis Pain Sales and Market Share by Regions (2011-2016)
Table Global Drugs for Osteoarthritis Pain Sales Share by Regions (2011-2016)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Regions (2011-2016)
Figure Global Drugs for Osteoarthritis Pain Sales Growth Rate by Regions (2011-2016)
Table Global Drugs for Osteoarthritis Pain Revenue and Market Share by Regions (2011-2016)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Regions (2011-2016)
Figure Global Drugs for Osteoarthritis Pain Revenue Growth Rate by Regions (2011-2016)
Table Global Drugs for Osteoarthritis Pain Sales and Market Share by Application (2011-2016)
Table Global Drugs for Osteoarthritis Pain Sales Share by Application (2011-2016)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Application (2011-2016)
Figure Global Drugs for Osteoarthritis Pain Sales Growth Rate by Application (2011-2016)
Figure United States Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure United States Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table United States Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016)
Table United States Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016)
Table United States Drugs for Osteoarthritis Pain Sales by Type (2011-2016)
Table United States Drugs for Osteoarthritis Pain Market Share by Type (2011-2016)
Table United States Drugs for Osteoarthritis Pain Sales by Application (2011-2016)
Table United States Drugs for Osteoarthritis Pain Market Share by Application (2011-2016)
Figure China Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure China Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table China Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016)
Table China Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016)
Table China Drugs for Osteoarthritis Pain Sales by Type (2011-2016)
Table China Drugs for Osteoarthritis Pain Market Share by Type (2011-2016)
Table China Drugs for Osteoarthritis Pain Sales by Application (2011-2016)
Table China Drugs for Osteoarthritis Pain Market Share by Application (2011-2016)
Figure Europe Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure Europe Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Sales by Type (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Market Share by Type (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Sales by Application (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Market Share by Application (2011-2016)
Figure Japan Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure Japan Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table Japan Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016)
Table Japan Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016)
Table Japan Drugs for Osteoarthritis Pain Sales by Type (2011-2016)
Table Japan Drugs for Osteoarthritis Pain Market Share by Type (2011-2016)
Table Japan Drugs for Osteoarthritis Pain Sales by Application (2011-2016)
Table Japan Drugs for Osteoarthritis Pain Market Share by Application (2011-2016)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table Southeast Asia Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016)
Table Southeast Asia Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016)
Table Southeast Asia Drugs for Osteoarthritis Pain Sales by Type (2011-2016)
Table Southeast Asia Drugs for Osteoarthritis Pain Market Share by Type (2011-2016)
Table Southeast Asia Drugs for Osteoarthritis Pain Sales by Application (2011-2016)
Table Southeast Asia Drugs for Osteoarthritis Pain Market Share by Application (2011-2016)
Figure India Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure India Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table India Drugs for Osteoarthritis Pain Sales by Manufacturers (2011-2016)
Table India Drugs for Osteoarthritis Pain Market Share by Manufacturers (2011-2016)
Table India Drugs for Osteoarthritis Pain Sales by Type (2011-2016)
Table India Drugs for Osteoarthritis Pain Market Share by Type (2011-2016)
Table India Drugs for Osteoarthritis Pain Sales by Application (2011-2016)
Table India Drugs for Osteoarthritis Pain Market Share by Application (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Global Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Global Market Share (2011-2016)
Table Novartis International Basic Information List
Table Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis International Drugs for Osteoarthritis Pain Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Drugs for Osteoarthritis Pain Global Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AbbVie Drugs for Osteoarthritis Pain Global Market Share (2011-2016)
Table Abiogen Pharma Basic Information List
Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Global Market Share (2011-2016)
Table Afferent Pharmaceuticals Basic Information List
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Global Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Pharma Drugs for Osteoarthritis Pain Global Market Share (2011-2016)
Table BioDelivery Sciences International Basic Information List
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Global Market Share (2011-2016)
Table CrystalGenomics Basic Information List
Table CrystalGenomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure CrystalGenomics Drugs for Osteoarthritis Pain Global Market Share (2011-2016)
Table Cytori Therapeutics Basic Information List
Table Daiichi Sankyo Basic Information List
Table Eli Lilly Basic Information List
Table Endo Pharmaceuticals Holdings Basic Information List
Table Horizon Pharma Basic Information List
Table ICeutica Basic Information List
Table Iroko Pharmaceuticals Basic Information List
Table Merck Basic Information List
Table Nuvo Research Basic Information List
Table Regeneron Pharmaceuticals Basic Information List
Table Sanofi Basic Information List
Table SantoSolve Basic Information List
Table Techfields Pharma Basic Information List
Table Winston Pharmaceuticals Basic Information List
Table Yooyoung Pharmaceutical Basic Information List
Table Zynerba Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Osteoarthritis Pain
Figure Manufacturing Process Analysis of Drugs for Osteoarthritis Pain
Figure Drugs for Osteoarthritis Pain Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015
Table Major Buyers of Drugs for Osteoarthritis Pain
Table Distributors/Traders List
Figure Global Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021)
Figure Global Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
Table Global Drugs for Osteoarthritis Pain Sales Forecast by Regions (2016-2021)
Table Global Drugs for Osteoarthritis Pain Sales Forecast by Type (2016-2021)
Table Global Drugs for Osteoarthritis Pain Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories